Quantcast

Latest Mitral regurgitation Stories

2011-04-05 00:26:08

Measuring oxidative stress may help doctors predict the risk of developing atrial fibrillation, the most common heart beat irregularity.

2011-04-04 08:00:00

NorthShore University HealthSystem's Ted Feldman, MD, Presents Late Breaking Data at American College of Cardiology Conference EMBARGOED FOR RELEASE UNTIL 8 AM, CDT, APRIL 4, 2011 EVANSTON, Ill., April 4, 2011 /PRNewswire-USNewswire/ -- NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented positive results from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy), that were concurrently published in The New England Journal of...

2011-04-04 08:00:00

NEW ORLEANS, April 4, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.

2011-04-01 00:14:17

NYU Langone Medical Center surgeons are performing minimally invasive heart surgery techniques on patients in their 80s and 90s.

2011-03-30 08:00:00

ABBOTT PARK, Ill., March 30, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of the company's catheter-based MitraClip® system for the treatment of mitral regurgitation (MR) in Australia.

2011-01-18 06:45:00

Cardiac Surgery Market to Reach Over $4.4 Billion by 2017 VANCOUVER, Jan.

2010-09-21 11:53:22

A percutaneous mitral valve clip designed to stop mitral valve regurgitation demonstrated clinical benefit as measured by the degree of mitral regurgitation.

2010-05-25 06:30:00

PARIS, May 25 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced new data from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial, which provide additional details about the safety and clinical benefit of Abbott's investigational MitraClip® system for the two causes of mitral regurgitation (MR) - functional MR (FMR) or degenerative MR (DMR).

2010-05-06 13:00:00

SAN DIEGO, May 6 /PRNewswire/ -- An innovative catheter-based procedure is providing relief to patients who suffer from shortness of breath and fluid overload as the result of a severely leaky heart valve, but who are too sick for open-chest surgery, according to a study presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd Annual Scientific Sessions.


Word of the Day
aphotic
  • Having no light.
  • Of or relating to the region of a body of water that is not reached by sunlight and in which photosynthesis is unable to occur.
The word 'aphotic' comes from Greek roots meaning 'without' and 'light'.
Related